Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 17-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Enoxaparin and clopidogrel may be superior for STEMI
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :
Eptifibatide adds to inhibition of GPIIb-IIIa by clopidogrel
Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. :
Clopidogrel is clearly a winner for STEMI, before and after PCI
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :
RIO-Europe adds further weight for rimonabant
Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. :
By Konopka Anna Spychalska Justyna Sitkiewicz Dariusz Zdebska Ewa Pilichowska Iwona Piotrowski Walerian Stepińska Janina
American Journal of Cardiovascular Drugs, Vol. 7, Iss. 6, 2007-01 ,pp. :